Tandem Diabetes Care
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $240,678 | $234,422 | $282,648 | $363,289 |
Gross Profit | 125,855 | 118,407 | 157,455 | 124,653 |
EBITDA | -50,818 | -116,421 | 6,121 | -16,538 |
EBIT | -55,185 | -120,732 | 1,876 | -20,749 |
Net Income | -52,400 | -130,556 | 755 | -23,251 |
Net Change In Cash | 240,678 | 234,422 | 282,648 | 363,289 |
Free Cash Flow | -15,702 | -21,243 | -38,756 | 21,540 |
Cash | 64,112 | 53,574 | 69,234 | 49,039 |
Basic Shares | 67,050 | 66,404 | 66,157 | 65,538 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $940,203 | $747,718 | $801,217 | $702,799 |
Gross Profit | 489,574 | 367,690 | 412,986 | 376,215 |
EBITDA | -99,127 | -194,657 | -72,314 | 36,498 |
EBIT | -99,285 | -210,372 | -86,644 | 22,653 |
Net Income | -96,025 | -222,611 | -94,594 | 15,566 |
Net Change In Cash | 940,203 | 747,718 | 801,217 | 702,799 |
Cost of Revenue | 100,509 | -23,585 | ||
Free Cash Flow | 4,994 | -83,413 | 7,512 | 87,848 |
Cash | 69,234 | 58,868 | 172,517 | 71,181 |
Basic Shares | 65,451 | 64,968 | 64,146 | 64,349 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.78 |
2025-03-31 | -$0.66 |
2024-12-31 | -$0.43 |
